Behavioral Activation for Geriatric Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a digital treatment called Behavioral Activation (BA) can reduce depression and neglect in older adults receiving help from Adult Protective Services. Participants will either receive this new digital treatment or continue with usual care to evaluate the new method's effectiveness. The trial targets individuals with an open APS case who show symptoms of depression, as indicated by a specific score on the PHQ-9 questionnaire. The researchers aim to determine if improving mood and motivation also reduces self-neglect behaviors. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance mental health care for older adults.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method is safe for geriatric depression?
Research has shown that Behavioral Activation (BA) is a safe and effective treatment for depression, particularly in older adults. Studies have found that it reduces symptoms such as loss of interest in activities and lack of motivation. These improvements facilitate participation in daily life. Importantly, BA is generally well-tolerated, with few reports of serious side effects. Evidence suggests it is a reliable option for managing depression, with minimal negative effects reported.12345
Why are researchers excited about this trial?
Researchers are excited about Behavioral Activation (BA) for geriatric depression because it offers a unique approach compared to traditional treatments like antidepressant medications and cognitive-behavioral therapy. Unlike these standard options, which often focus on altering brain chemistry or challenging thought patterns, BA directly targets the patient's engagement in positive and rewarding activities. This method empowers older adults by helping them reconnect with pleasurable activities and social interactions, potentially leading to an improvement in mood and overall well-being. Moreover, BA can be particularly appealing as it minimizes reliance on medications, which can have various side effects, and provides a more active, empowering role for the patient in their own treatment.
What evidence suggests that this trial's treatments could be effective for geriatric depression?
Research shows that Behavioral Activation (BA), which participants in this trial may receive, effectively treats depression in older adults. Studies have found that BA reduces depression and encourages healthy behaviors in this age group. For instance, one study reported that 71% of participants experienced a decrease in depression levels after using BA. Another review of multiple studies confirmed that BA is easy to use for managing depression. These findings suggest that BA could be a promising way to improve mental health in older adults.16789
Who Is on the Research Team?
Leila Wood, PhD, MSSW
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for Adult Protective Services (APS) clients who are experiencing depression and may be neglecting themselves or others. Participants should be able to use an iPad, computer, or smartphone.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive evidence-based treatment for depression delivered over an iPad, computer, or smartphone
Follow-up
Participants are monitored for changes in depression, apathy, and social connection
What Are the Treatments Tested in This Trial?
Interventions
- Intervention-Behavioral Activation (BA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
National Institute on Aging (NIA)
Collaborator